More news and press

Ginkgo Bioworks Adopts Inscripta®’s Onyx® Digital Genome Engineering Platform to Continue Accelerating its Genome Editing Throughput
Inscripta®, the Digital Genome Engineering Company, today announced that Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell…
Read More
Inscripta® Appoints Kristala Prather, PhD to its Board of Directors
Inscripta adds a distinguished MIT Professor and synthetic biology pioneer, Dr. Kristala Prather, to the Board of Directors.
Read More
Hunterian Medicine® Licenses Inscripta’s MAD7™ Nuclease to Advance Gene Editing Research and Development
Inscripta and Hunterian pioneer new program to provide access to novel CRISPR enzymes for biotherapeutic development…
Read More
Amyris Partners with Inscripta® to Enhance Development of Sustainable Ingredients Using the Onyx® Genome Engineering Platform
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer…
Read More
Inscripta® Announces the First Commercial Shipment of Its Onyx® Digital Genome Engineering Platform and Closes $150 Million in New Financing
GeneMill at the University of Liverpool receives first benchtop Onyx platform in EuropeFinancing round led by Fidelity and T. Rowe Price funds…
Read More
Inscripta® Appoints Sri Kosaraju as President and CEO
Experienced growth-company leader joins as Inscripta embarks on next phase of commercial launch for its Onyx digital genome engineering platform…
Read More
Inscripta® Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform
New Funding Brings Total Amount Raised by the Company to $259.5 Million…
Read More
Inscripta® Launches the World’s First Benchtop Platform for Digital Genome Engineering
The Onyx® platform enables scientists to create libraries of millions of precisely engineered single cells in one experiment through a fully…
Read More
Inscripta® Is the Presenting Sponsor of SynBioBeta 2019
Company is launching the world’s first benchtop platform for scalable Digital Genome Engineering at the conference…
Read More
Inscripta® Appoints Jim Lalonde to Lead Microbial Digital Genome Engineering Business and Portfolio Strategy
Inscripta today named Jim Lalonde, Ph.D. to its management team…
Read More
1 of 3